The Company has received written notice of termination of the CO2 Injection Agreement from
The Company recommends that investors and all interested parties visit its website www.biloximarshlandscorp.com to view historical press releases, historical financial statements, and other relevant information. All inquiries should be made through the Contact Mailbox on the Company's website: http://www.biloximarshlandscorp.com/contact/.
Contact:
504-837-4337
(C) 2024 Electronic News Publishing, source